Asymmetrex, LLC
Boston, MA
- UEI
- D3JTJM83KNT3
- CAGE
- 4GY52
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- SAM.gov registration date
- Physical address
- 39 Sheridan St, Jamaica Plain, MA 02130, USA
- Website
- asymmetrex.co
- Founded
- 2013
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ship Of Theseus LLC | Eagleville, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Minutia Inc. | Oakland, CA | — |
| Ossium Health, Inc. | Indianapolis, IN | 325414 Biological Product (except Diagnostic) Manufacturing |
| Endomimetics, Inc. | Birmingham, AL | — |
| SAFI Biotherapeutics Inc. | Cambridge, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Asymmetrex, LLC is a minority-owned, for-profit limited liability company registered in SAM.gov since December 2018, specializing in advanced stem cell research and technology development. The company focuses on innovative solutions for stem cell counting and characterization, with a particular emphasis on developing computational and technological methods to quantify and analyze tissue stem cells across various research and medical applications.
Through federal grant awards from the National Heart, Lung, and Blood Institute, Asymmetrex, LLC has been developing cutting-edge technologies for automated electronic tissue stem cell counting. Specifically, the company was awarded two significant grants (R44HL154900 and R43HL154900) aimed at designing and building the first laboratory instrument capable of providing automated electronic counting of tissue stem cells. The primary goal of these projects is to create a practical solution for determining the specific fraction of stem cells in research, medical, and biomanufacturing contexts, addressing a critical gap in current stem cell research methodologies. The grants, running from 2020 to 2026, involve developing a small-footprint benchtop counting instrument that can automate cell culture, counting, and computational analysis, with a focus on hematopoietic and mesenchymal stem cells. Additionally, Asymmetrex has received a sub-award (W911NF1730003T0227D3JTJM83KNT3) related to developing technology for rapid inline determination of stem cell-specific numbers during biomanufacturing processes, further demonstrating their expertise in advanced stem cell technology solutions.
Quick answers
Is Asymmetrex, LLC registered in SAM.gov?
Yes. Asymmetrex, LLC's SAM.gov registration is active through June 9, 2027.
What is Asymmetrex, LLC's most recent federal award?
Asymmetrex, LLC's most recent federal grant award is Design and production of an automated electronic tissue stem cell counter (R44HL154900), from National Heart Lung and Blood Institute (NIH), on September 23, 2020.
On GovTribe
See Asymmetrex, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors